Loteprednol etabonate [clinicaltrials_resource:5feaa44002e530ab859f334a0f4ca798]
Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation [clinicaltrials:NCT00366691]clinicaltrials:NCT00420628Zylet vs TobraDex in Blepharokeratoconjunctivitis [clinicaltrials:NCT00447577]Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex [clinicaltrials:NCT00532961]Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye [clinicaltrials:NCT00560638]clinicaltrials:NCT00645671Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge Model [clinicaltrials:NCT00689078]clinicaltrials:NCT00699153clinicaltrials:NCT00705159Intraocular Pressure With Loteprednol and Dexamethasone [clinicaltrials:NCT00781300]Use of Loteprednol for Contact Lens Intolerance and Dryness [clinicaltrials:NCT00817557]clinicaltrials:NCT00834171clinicaltrials:NCT01010633clinicaltrials:NCT01028027clinicaltrials:NCT01060072clinicaltrials:NCT01107405Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification [clinicaltrials:NCT01193504]Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery [clinicaltrials:NCT01344226]A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery [clinicaltrials:NCT01384266]clinicaltrials:NCT01435460A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5% [clinicaltrials:NCT01437982]Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis [clinicaltrials:NCT01443442]Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis [clinicaltrials:NCT01456780]Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children. [clinicaltrials:NCT01475643]Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate [clinicaltrials:NCT01692652]Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5% [clinicaltrials:NCT01695668]clinicaltrials:NCT01721694Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing [clinicaltrials:NCT01724892]clinicaltrials:NCT01736527Efficacy of Loteprednol Ointment Following Eyelid Surgery [clinicaltrials:NCT01749241]Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca [clinicaltrials:NCT01817582]clinicaltrials:NCT01853696Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [clinicaltrials:NCT01996839]A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® [clinicaltrials:NCT02028312]Using in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Steroid Treatment in Dry Eye Disease [clinicaltrials:NCT02106377]The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease [clinicaltrials:NCT02120079]clinicaltrials:NCT02163824Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease [clinicaltrials:NCT02188160]Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [clinicaltrials:NCT02208297]clinicaltrials:NCT02218489
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Loteprednol etabonate [clinicaltrials_resource:5feaa44002e530ab859f334a0f4ca798]
Bio2RDF identifier
5feaa44002e530ab859f334a0f4ca798
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5feaa44002e530ab859f334a0f4ca798
identifier
clinicaltrials_resource:5feaa44002e530ab859f334a0f4ca798
title
Loteprednol etabonate
@en
type
label
Loteprednol etabonate [clinicaltrials_resource:5feaa44002e530ab859f334a0f4ca798]
@en